Bausch & Lomb director granted 15,842 RSUs

Bausch & Lomb Corp director John Paulson reported receiving a stock-based compensation award rather than making an open-market trade.

Rhea-AI Filing Summary

Bausch & Lomb Corp director John Paulson reported receiving a stock-based compensation award rather than making an open-market trade. He acquired 15,842 common shares at an accounting value of $15.78 per share through a grant of restricted share units under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan.

Following this award, his direct holdings rose to 89,823 common shares. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders and will be settled in common shares when vested.

Insider Trade Summary

Grant/Award: 15,842 shares

Grant/Award 1 txn

Insider Paulson John

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	15,842	$15.78	$250K

Holdings After Transaction: Common Shares, No Par Value — 89,823 shares (Direct)

Footnotes (1)

1. F1. Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.

Key Figures

RSU grant size: 15,842 shares RSU grant price: $15.78 per share Shares held after grant: 89,823 shares

3 metrics

RSU grant size 15,842 shares Restricted share unit award to non-employee director

RSU grant price $15.78 per share Accounting value per common share for the RSU grant

Shares held after grant 89,823 shares Director John Paulson’s direct common share holdings post-transaction

Key Terms

restricted share units ("RSUs"), 2022 Omnibus Incentive Plan, non-employee directors

3 terms

restricted share units ("RSUs") financial

"Reflects the annual grant of restricted share units ("RSUs") to non-employee directors"

2022 Omnibus Incentive Plan financial

"under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated"

non-employee directors financial

"annual grant of restricted share units ("RSUs") to non-employee directors"

Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Bausch & Lomb Corp (BLCO) director John Paulson report?

Director John Paulson reported acquiring 15,842 common shares of Bausch & Lomb Corp as a grant of restricted share units. This was a compensation-related award under the company’s 2022 Omnibus Incentive Plan, not an open-market stock purchase or sale.

Was John Paulson’s Bausch & Lomb (BLCO) Form 4 transaction a stock purchase?

No, the Form 4 shows a grant of 15,842 restricted share units to John Paulson, valued at $15.78 per share. This reflects stock-based compensation for a non-employee director, rather than a discretionary open-market buy or sell transaction.

How many Bausch & Lomb (BLCO) shares does John Paulson hold after this Form 4?

After the reported grant, John Paulson directly holds 89,823 common shares of Bausch & Lomb Corp. This increase comes from the award of 15,842 restricted share units that will settle in common shares once they vest under the plan.

What are the terms of John Paulson’s Bausch & Lomb (BLCO) RSU grant?

The filing states the 15,842 restricted share units were granted under the 2022 Omnibus Incentive Plan for non-employee directors. These RSUs vest on the date immediately preceding the conclusion of the next annual meeting of shareholders and are then settled in common shares.

At what price were John Paulson’s Bausch & Lomb (BLCO) RSUs valued?

The restricted share unit grant to John Paulson is reported at $15.78 per common share for 15,842 shares. This value is an accounting grant price used for the award and does not represent an open-market trade price paid by the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/28/2026 - 05:07 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Paulson John

(Last) (First) (Middle)

C/O BAUSCH + LOMB CORPORATION

520 APPLEWOOD CRESCENT

(Street)

VAUGHAN L4K 4B4

(City) (State) (Zip)

ONTARIO, CANADA

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	05/26/2026		A		15,842(1)	A	$15.78	89,823	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest on the date immediately preceding the conclusion of the next annual meeting of shareholders.

	/s/ Debra E. Levin, attorney-in-fact	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)